FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Pharmacol Res Perspect / Equine hepatocytes: isolation, cryopreservation, and applica...
Pharmacology research & perspectives2016; 4(5); e00268; doi: 10.1002/prp2.268

Equine hepatocytes: isolation, cryopreservation, and applications to in vitro drug metabolism studies.

Abstract: Despite reports of the successful isolation of primary equine hepatocytes, there are no published data regarding the successful cryopreservation of these isolated cells. In this study, a detailed description of the procedures for isolation, cryopreservation, and recovery of equine hepatocytes are presented. Furthermore, the intrinsic clearance (Cl) and production of metabolites for three drugs were compared between freshly isolated and recovered cryopreserved hepatocytes. Primary equine hepatocytes were isolated using a two-step collagenase perfusion method, with an average cell yield of 2.47 ± 2.62 × 10 cells/g of perfused liver tissue and viability of 84.1 ± 2.62%. These cells were cryopreserved with William's medium E containing 10% fetal bovine serum with 10% DMSO. The viability of recovered cells, after a 30% Percoll gradient, was 77 ± 11% and estimated recovery rate was approximately 27%. These purified cells were used to determine the in vitro Cl of three drugs used in equine medicine; omeprazole, flunixin, and phenylbutazone, via the substrate depletion method. Cryopreserved suspensions gave a comparable estimation of Cl compared to fresh cells for these three drugs as well as producing the same metabolites. This work paves the way for establishing a bank of cryopreserved equine hepatocytes that can be used for estimating pharmacokinetic parameters such as the hepatic metabolic in vivo clearance of a drug as well as producing horse-specific drug metabolites.
Get Full Text
Publication Date: 2016-09-30 PubMed ID: 27713829PubMed Central: PMC5045944DOI: 10.1002/prp2.268Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explored the isolation, cryopreservation, and recovery of equine (horse) liver cells, or hepatocytes, bringing forth an effort to forge a ‘bank’ of these preserved cells for use in the estimation of drug metabolism rates in horses, in addition to producing horse-specific drug metabolites.

Isolation of Hepatocytes

  • The author’s study details the process of isolating primary equine hepatocytes which was done with a two-step collagenase perfusion method.
  • This method yielded an average of 2.47 ± 2.62 x 10 cells per gram of the perfused liver tissue with a viability rate of 84.1 ± 2.62%.

Cryopreservation and Recovery

  • The isolated hepatocytes were cryopreserved in a William’s medium E containing 10% fetal bovine serum with 10% DMSO, which is a cryoprotectant that prevents ice crystal formation in cells during the freezing process.
  • The viability of the cells was tested after their recovery from a 30% Percoll gradient, which allowed for the separation of viable and non-viable cells.
  • The viability of the recovered cells was 77 ± 11% and the estimated recovery rate was approximately 27%.

In Vitro Drug Metabolism Studies

  • The study also details the use of these cryopreserved equine hepatocytes in determining the in vitro clearance of three drugs commonly used in equine medicine. These were omeprazole, flunixin, and phenylbutazone.
  • The clearance was determined via the substrate depletion method which measures the decrease in concentration of the drug over time due to metabolism.
  • The cryopreserved cells were found to deliver comparable estimations of clearance as fresh cells did for these three drugs, and also produced the same metabolites.

Implications of the Study

  • The success of these procedures holds promise for the establishment of a ‘cell bank’ of cryopreserved equine hepatocytes.
  • This resource could help to estimate pharmacokinetic parameters such as the in vivo clearance of a drug in the horse’s liver.
  • It could also assist in producing horse-specific drug metabolites, which enhances the understanding of how different substances will be metabolized specifically by horses, increasing the efficiencies of drugs for equine use.

Cite This Article

APA
Shibany KA, Tötemeyer S, Pratt SL, Paine SW. (2016). Equine hepatocytes: isolation, cryopreservation, and applications to in vitro drug metabolism studies. Pharmacol Res Perspect, 4(5), e00268. https://doi.org/10.1002/prp2.268

Publication

Pharmacology research & perspectives
ISSN: 2052-1707
NlmUniqueID: 101626369
Country: United States
Language: English
Volume: 4
Issue: 5
Pages: e00268
PII: e00268

Researcher Affiliations

Shibany, Khaled A
  • School of Veterinary Medicine and Sciences University of Nottingham College Road Sutton Bonington Leicestershire LE12 5RD United Kingdom.
Tötemeyer, Sabine
  • School of Veterinary Medicine and Sciences University of Nottingham College Road Sutton Bonington Leicestershire LE12 5RD United Kingdom.
Pratt, Stefanie L
  • School of Veterinary Medicine and Sciences University of Nottingham College Road Sutton Bonington Leicestershire LE12 5RD United Kingdom.
Paine, Stuart W
  • School of Veterinary Medicine and Sciences University of Nottingham College Road Sutton Bonington Leicestershire LE12 5RD United Kingdom.

References

This article includes 31 references
  1. Adams RM, Wang M, Crane AM, Brown B, Darlington GJ, Ledley FD. Effective cryopreservation and long-term storage of primary human hepatocytes with recovery of viability, differentiation, and replicative potential.. Cell Transplant 1995 Nov-Dec;4(6):579-86.
    pubmed: 8714779doi: 10.1177/096368979500400607google scholar: lookup
  2. Bachmann K, Byers J, Ghosh R. Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes.. Xenobiotica 2003 May;33(5):475-83.
    pubmed: 12746104doi: 10.1080/0049825031000076177google scholar: lookup
  3. Bakala A, Karlik W, Wiechetek M. Preparation of equine isolated hepatocytes.. Toxicol In Vitro 2003 Oct-Dec;17(5-6):615-21.
    pubmed: 14599453doi: 10.1016/s0887-2333(03)00112-7google scholar: lookup
  4. Berry MN, Edwards AM. The hepatocyte review. .
  5. . Economic Impact of British Racing 2013 Forward Executive Summary Introduction Section 1 : Overall Economic Impact Racing's Position in the Leisure Industry Feature Articles. .
  6. Dambach DM, Andrews BA, Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models.. Toxicol Pathol 2005;33(1):17-26.
    pubmed: 15805052doi: 10.1080/01926230590522284google scholar: lookup
  7. Diener B, Utesch D, Beer N, Dürk H, Oesch F. A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics.. Cryobiology 1993 Apr;30(2):116-27.
    pubmed: 8319482doi: 10.1006/cryo.1993.1011google scholar: lookup
  8. Dou M, de Sousa G, Lacarelle B, Placidi M, Lechene de la Porte P, Domingo M, Lafont H, Rahmani R. Thawed human hepatocytes in primary culture.. Cryobiology 1992 Aug;29(4):454-69.
    pubmed: 1395683doi: 10.1016/0011-2240(92)90048-7google scholar: lookup
  9. Griffin SJ, Houston JB. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance.. Drug Metab Dispos 2004 May;32(5):552-8.
    pubmed: 15100178doi: 10.1124/dmd.32.5.552google scholar: lookup
  10. Hewitt NJ, de Kanter R, LeCluyse E. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?. Chem Biol Interact 2007 May 20;168(1):51-65.
    pubmed: 17239835doi: 10.1016/j.cbi.2006.12.009google scholar: lookup
  11. Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.. Biochem Pharmacol 1994 Apr 29;47(9):1469-79.
    pubmed: 8185657doi: 10.1016/0006-2952(94)90520-7google scholar: lookup
  12. Innes GK, Fuller BJ, Hobbs KE. Functional testing of hepatocytes following their recovery from cryopreservation.. Cryobiology 1988 Feb;25(1):23-30.
    pubmed: 3349809doi: 10.1016/0011-2240(88)90016-8google scholar: lookup
  13. Jedziniak P, Szprengier‐juszkiewicz T. Determination of phenylbutazone and oxyphenbutazone in bovine plasma using high performance liquid chromatography with UV detection. Bull Vet Inst Pulawy 49: 223–226.
  14. Jedziniak P, Szprengier‐Juszkiewicz T, Olejnik M, Jaroszewski J. Determination of flunixin and 5‐hydroxyflunixin in bovine plasma with HPLC‐UV method development, validation and verification. Bull Vet Inst Pulawy 51: 261–266.
  15. Jouin D, Blanchard N, Alexandre E, Delobel F, David-Pierson P, Lavé T, Jaeck D, Richert L, Coassolo P. Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance.. Eur J Pharm Biopharm 2006 Jul;63(3):347-55.
    pubmed: 16621491doi: 10.1016/j.ejpb.2006.01.014google scholar: lookup
  16. Kanazawa H, Okada A, Matsushima Y, Yokota H, Okubo S, Mashige F, Nakahara K. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.. J Chromatogr A 2002 Mar 8;949(1-2):1-9.
    pubmed: 11999727doi: 10.1016/s0021-9673(01)01508-4google scholar: lookup
  17. Kreamer BL, Staecker JL, Sawada N, Sattler GL, Hsia MT, Pitot HC. Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations.. In Vitro Cell Dev Biol 1986 Apr;22(4):201-11.
    pubmed: 2871008doi: 10.1007/bf02623304google scholar: lookup
  18. Li AP. Human hepatocytes: isolation, cryopreservation and applications in drug development.. Chem Biol Interact 2007 May 20;168(1):16-29.
    pubmed: 17270162doi: 10.1016/j.cbi.2007.01.001google scholar: lookup
  19. McGinnity DF, Soars MG, Urbanowicz RA, Riley RJ. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.. Drug Metab Dispos 2004 Nov;32(11):1247-53.
    pubmed: 15286053doi: 10.1124/dmd.104.000026google scholar: lookup
  20. Naritomi Y, Terashita S, Kimura S, Suzuki A, Kagayama A, Sugiyama Y. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.. Drug Metab Dispos 2001 Oct;29(10):1316-24.
    pubmed: 11560875
  21. Neto LM, Andraus MH, Salvadori MC. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.. J Chromatogr B Biomed Appl 1996 Apr 12;678(2):211-8.
    pubmed: 8738024doi: 10.1016/0378-4347(95)00508-0google scholar: lookup
  22. . SciKon mouse hepatocyte care manual. Pp. 1–3.
  23. Seglen PO. Preparation of isolated rat liver cells.. Methods Cell Biol 1976;13:29-83.
    pubmed: 177845doi: 10.1016/s0091-679x(08)61797-5google scholar: lookup
  24. Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing.. Toxicol Res (Camb) 2013 Jan 1;2(1):23-39.
    pmc: PMC3593300pubmed: 23495363doi: 10.1039/c2tx20051agoogle scholar: lookup
  25. Sosef MN, Baust JM, Sugimachi K, Fowler A, Tompkins RG, Toner M. Cryopreservation of isolated primary rat hepatocytes: enhanced survival and long-term hepatospecific function.. Ann Surg 2005 Jan;241(1):125-33.
    pmc: PMC1356855pubmed: 15622000doi: 10.1097/01.sla.0000149303.48692.0fgoogle scholar: lookup
  26. Stefanski A, Mevissen M, Möller AM, Kuehni-Boghenbor K, Schmitz A. Induction of cytochrome P450 enzymes in primary equine hepatocyte culture.. Toxicol In Vitro 2013 Oct;27(7):2023-30.
    pubmed: 23916975doi: 10.1016/j.tiv.2013.07.009google scholar: lookup
  27. TENNANT JR. EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY.. Transplantation 1964 Nov;2:685-94.
    pubmed: 14224649doi: 10.1097/00007890-196411000-00001google scholar: lookup
  28. Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD. Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation.. Liver Transpl 2010 Feb;16(2):229-37.
    pubmed: 20104500doi: 10.1002/lt.21983google scholar: lookup
  29. Toutain PL, Lassourd V. Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse.. Equine Vet J 2002 May;34(3):242-9.
    pubmed: 12108741doi: 10.2746/042516402776185985google scholar: lookup
  30. Utesch D, Diener B, Molitor E, Oesch F, Platt KL. Characterization of cryopreserved rat liver parenchymal cells by metabolism of diagnostic substrates and activities of related enzymes.. Biochem Pharmacol 1992 Jul 22;44(2):309-15.
    pubmed: 1642645doi: 10.1016/0006-2952(92)90014-agoogle scholar: lookup
  31. Wasfi IA, Boni NS, Abdel Hadi A, Elghazali M, Zorob O, Alkatheeri NA, Barezaiq IM. Pharmacokinetics, metabolism and urinary detection time of flunixin after intravenous administration in camels.. J Vet Pharmacol Ther 1998 Jun;21(3):203-8.
    pubmed: 9673961doi: 10.1046/j.1365-2885.1998.00122.xgoogle scholar: lookup

Citations

This article has been cited 1 times.
  1. Nowak MR, Zdunek R, Pliński E, Świątek P, Strzelecka M, Malinka W, Plińska S. Recognition of Pharmacological Bi-Heterocyclic Compounds by Using Terahertz Time Domain Spectroscopy and Chemometrics. Sensors (Basel) 2019 Jul 30;19(15).
    doi: 10.3390/s19153349pubmed: 31366175google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.